Search Results 321-330 of 17344 for LDL
This is a Phase III, placebo-controlled, double-blind, randomized study in participants with ASCVD and elevated LDL-C despite maximum tolerated dose of LDL ...
Ddyslipidemia – LDL cholesterol >190 mg/dl, or current NCEP criteria for statin treatment based on Framingham Risk Score, if personal physician prescribes ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Dyslipidemia – Triglycerides > 250 mg/dl or cholesterol > 220 mg/dl or HDL < 35 mg/dl or LDL > 200 or use of lipid lowering medications;; Sleep Apnea – A ...
About this study. The purpose is to put the information into a very large database, which can then be used to improve patient care and achieve the best ...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...
This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.
Pleural fluid lactate dehydrogenase (L), ECOG performance score (E), serum neutrophil-to-lymphocyte ratio (N) and tumor type (T), or LENT, prognostic score ...
... (LDL \> 130 mg /dl or HDL \< 40 mg/dl or fasting triglycerides \> 150 mg/dl or on lipid lowering therapy); smoking; non-insulin dependent diabetes or insulin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.